Detection of Methylated SEPT9 in Plasma Is a Reliable Screening Method for Both Left- and Right-Sided Colon Cancers

BACKGROUND: Methylated Septin 9 (SEPT9) is a sensitive biomarker for colorectal cancer (CRC) from peripheral blood. However, its relationship to cancer localization, guaiac-based fecal occult blood test (gFOBT) and carcinoembryonic antigen (CEA) have not been described. METHODOLOGY/PRINCIPAL FINDING...

Descripción completa

Detalles Bibliográficos
Autores principales: Tóth, Kinga, Sipos, Ferenc, Kalmár, Alexandra, Patai, Árpád V., Wichmann, Barnabás, Stoehr, Robert, Golcher, Henriette, Schellerer, Vera, Tulassay, Zsolt, Molnár, Béla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3457959/
https://www.ncbi.nlm.nih.gov/pubmed/23049919
http://dx.doi.org/10.1371/journal.pone.0046000

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3457959/
https://www.ncbi.nlm.nih.gov/pubmed/23049919
http://dx.doi.org/10.1371/journal.pone.0046000

Ejemplares similares